1.	Phase I/II Study of Lometrexol in Patients with Ovarian Adenocarcinoma Phase: Phase II, Phase I Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: Protocol IDs: MSKCC-91173, NCI-V92-0026
2.	Phase II Study of Lometrexol and Folic Acid in Patients With Previously Treated Stage IIIB or IV Non-Small Cell Lung Cancer Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: TULA-T064031, USO-01103, NCT00033722
3.	Phase I Study of Lometrexol/Folic Acid for Solid Tumors and Lymphomas (Summary Last Modified 08/97) Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MCV-MCC-9408-2B, NCI-T94-0121O, T94-0121
4.	Phase I Study of Lometrexol/Folic Acid for Advanced Solid Tumors (Summary Last Modified 02/96) Phase: Phase I Type: Treatment Status: Completed Age: 21 and over Sponsor: NCI Protocol IDs: LAC-USC-0C941, NCI-T94-0142H, T94-0142
5.	Phase I Study of Lometrexol, Paclitaxel, and Folic Acid in Patients With Locally Advanced or Metastatic Solid Tumors Phase: Phase I Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: UCLA-0005068, TULA-T3004, NCI-G01-2017, NCT00024310